Patterns of multiple primaries in fortyfour cancer patients: a single-center clinical experience

Mehmet Esat Duymus, Tolga Koseci, Mehmet Serindere, Meral Ceylan, Abdullah Bulgurcu, Ozlem Ipci, Cemile Karadeniz, Yusuf Murat Bag, Dilsa Mizrak Kaya

Vol 19, No 1 (2023)

Research paper

Radioligand therapy — personalized treatment for patients with neuroendocrine tumors

Agnieszka Kolasińska-Ćwikła

Vol 19, No 2 (2023)

Review paper

Spermatic cord tumors — review of the literature

Krzysztof Kowalik, Andrzej Modrzejewski, Adam Kurpik

Vol 19, No 3 (2023)

Review paper

Recommendations for prevention of SARS-CoV-2 infection in immunocompromised patients

Krzysztof Tomasiewicz, Alicja Dębska-Ślizień, Magdalena Durlik, Krzysztof Giannopoulos, Iwona Hus, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Long-term overall survival in a patient with non-small cell lung cancer with KRAS mutation

Izabela Chmielewska

Vol 19, No 2 (2023)

Case report

Microwave ablation of colorectal cancer lung metastases — the first experience in Poland

Grzegorz Rosiak, Maciej Krzakowski, Krzysztof Milczarek, Dariusz Konecki, Olgierd Rowiński

Vol 19, No 2 (2023)

Research paper

Adjuvant radiotherapy in the management of porocarcinoma with lymphatic micrometastasis

Alper Kahvecioglu, Gonca Elcin, Saadettin Kilickap, Ozay Gokoz, Gozde Yazici

Vol 19, No 2 (2023)

Case report

Diagnosis and treatment of rhabdomyosarcomas

Michał Łomiak, Tomasz Świtaj, Mateusz Spałek, Joanna Radzikowska, Marzanna Chojnacka, Sławomir Falkowski, Michał Wągrodzki, Wojciech Kukwa, Anna Szumera-Ciećkiewicz, Piotr Rutkowski, Anna M. Czarnecka

Vol 19, No 4 (2023)

Review paper

Common statement of experts of the Polish Oncological Society, Polish Lung Cancer Group, Polish Society of Lung Diseases, Polish Society of Gastroenterology, Polish Society of Endocrinology, and the Polish Society of Cardiology for minimal requirements in diagnosis and monitoring of selected adverse events of immunotherapy in oncological patients

Bożena Cybulska-Stopa, Adam Antczak, Dariusz M. Kowalski, Beata Kos-Kudła, Tomasz Kubiatowski, Przemysław Leszek, Adam Maciejczyk, Jarosław Reguła, Paweł Wiechno, Piotr Rutkowski

Vol 19, No 2 (2023)

Guidelines / Expert consensus

Epithelioid inflammatory myofibroblastic sarcoma of the lung ALK+/ NTRK+/ PD-L1+

Gabriele Gaggero, Davide Taietti, Veronica Parrella, Camilla Gennaioli, Antonio Guadagno

Vol 19, No 2 (2023)

Clinical vignette

A case of pathologic complete response after neoadjuvant triplet chemotherapy for locally advanced colon cancer with mismatch repair enzyme proficiency

Mehmet Zahid Kocak, Murat Cakir, Ulku Kerimoglu, Murat Araz, Melek Karakurt Eryilmaz, Perran Fulden Yumuk, Mehmet Artac

Vol 19, No 2 (2023)

Case report

Management of febrile neutropenia in a breast cancer patient with SARS-CoV-2 infection during dose-dense adjuvant chemotherapy

Joanna Terebińska, Robert Wojciechowski, Filip Zieliński, Anna Skrzypczyk-Ostaszewicz, Arkadiusz Zegadło, Emil Lisiak, Artur Maliborski, Renata Duchnowska

Vol 19, No 2 (2023)

Clinical vignette

Leptomeningeal metastasis in primary uterine cervical cancer: a rare case and review of the literature

Alper Kahvecioglu, Sezin Yuce Sari, Hasan Cagri Yildirim, Zafer Arik, Melis Gultekin, Ferah Yildiz

Vol 19, No 3 (2023)

Case report

Immunotherapy for gastroesophageal cancer

Marek Gełej, Barbara Radecka, Monika Kotyla, Weronika Radecka, Tomasz Kubiatowski

Vol 19, No 3 (2023)

Review paper

Strikingly high activity of metronomic chemotherapy in a patient with locally advanced, life-threatening cutaneous squamous-cell cancer — case report and discussion of the literature

Łukasz Kwinta, Piotr J. Wysocki

Vol 19, No 3 (2023)

Case report

Immunotherapy for colorectal cancer

Barbara Radecka, Marek Gełej, Monika Kotyla, Tomasz Kubiatowski

Vol 19, No 3 (2023)

Review paper

Male breast cancer: a budding and unaddressed issue

Abhishek Soni, Diptajit Paul, Monica Verma, Paramjeet Kaur, Ashok Chauhan, Vivek Kaushal

Vol 19, No 3 (2023)

Review paper

Replacement of ALK inhibitors as an effective strategy for reducing drug toxicity in non-small cell lung cancer patients with ALK gene rearrangement

Michał Gil, Izabela Chmielewska, Paweł Krawczyk, Przemysław Niziński, Maciej Strzemski, Janusz Milanowski

Vol 19, No 3 (2023)

Case report

Efficacy of chemoimmunotherapy in a lung adenocarcinoma patient with mutations in the KRAS and STK11

Natalia Krzyżanowska, Paweł Krawczyk, Izabela Chmielewska, Tomasz Jankowski, Kamila Wojas-Krawczyk, Janusz Milanowski

Vol 19, No 3 (2023)

Case report

Hypopituitarism as a rare complication of lung cancer immunotherapy

Jakub Krzysztof Gałązka, Anna Rudzińska, Grzegorz Rudzki, Katarzyna Szklener, Sławomir Mańdziuk

Vol 19, No 3 (2023)

Clinical vignette

Optimization of diagnostic and therapeutic management in patients with stage III non-small cell lung cancer — experience of the centers in Poznań

Maciej Bryl, Piotr Milecki, Mirosława Matecka-Nowak, Jolanta Lubin, Anna Rucińska, Cezary Piwkowski

Vol 19, No 3 (2023)

Review paper

Bisphosphonate treatment as a safe choice for treating lung metastases of recurrent giant cell tumor of bone

Hans Kristian Nugraha, Putu Bihan Surya Kinanta, I Gede Eka Wiratnaya

Vol 19, No 3 (2023)

Case report

Pathological complete response and survival of HER2-positive invasive breast cancer following docetaxel, carboplatin, and trastuzumab neoadjuvant therapy: a Vietnamese experience

Duc Thanh Le, Tu Anh Do, Lap Thanh Bui, Kien Hung Do, Chu Van Nguyen

Vol 19, No 4 (2023)

Research paper

Potassium imbalances induced by systemic cancer therapy: pathophysiology and potential therapeutic strategies

Datis Kalali

Vol 20, No 1 (2024)

Review paper

Comprehensive geriatric assessment and clinical outcomes of frail older adults with diffuse large B-cell lymphoma: a meta-analysis

Teodoro J. Oscanoa, Xavier Vidal, Brady E. Beltran, Roman Romero-Ortuno

Vol 19, No 6 (2023)

Review paper